P17108 AF NFT

Interleukin-2

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeiar5pqmpqb4cbeymxsirlddrjdy6uuocelqpdjgcy4fzndr3jkxdq/metadata.json
IPFS of structure file: 
bafybeibwumdc7r5eqr6prvzrjimzvnubkldnsbr7wc6mjm7d6asnfx5nv4/AF-P17108-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x52eed1164b71286E6413de11A2358780D6d90f8B
First NFT owner address (bech32): 
genesis12thdz9jtwy5xueqnmcg6ydv8srtdjrutpyg0la
Current NFT ID #187907 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
187907
Accession (UniProt):
P17108
Name::
Interleukin-2
Experimental Method:
Predicted structure
Sequence source:
RATTUS NORVEGICUS

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT P17108 research and analysis (ICN3D with VR)

FASTA sequences

>sp|P17108|IL2_RAT Interleukin-2 OS=Rattus norvegicus OX=10116 GN=Il2 PE=2 SV=1 MYSMQLASCVALTLVLLVNSAPTSSPAKETQQHLEQLLLDLQVLLRGIDNYKNLKLPMMLTFKFYLPKQATELKHLQCLENELGALQRVLDLTQSKSFHLEDAGNFISNIRVTVVKLKGSENKFECQFDDEPATVVEFLRRWIAICQSIISTMTQ